Skip to main content
Premium Trial:

Request an Annual Quote

Tabula Rasa Healthcare, OneOme Form Precision Prescribing Alliance

NEW YORK — Tabula Rasa HealthCare said on Thursday that it has signed an agreement to combine its MedWise medication decision support software with OneOme's RightMed pharmacogenomics test.

Financial and other terms of the deal were not disclosed.

MedWise reviews a patient's medication regimen in order to identify accumulative multi-drug interactions and support treatment decision-making. RightMed analyzes 27 genes in order to predict how a patient will respond to a particular drug.

"The additive power of combining OneOme's RightMed Test with … MedWise technology will bring more precision pharmacotherapy opportunities to our partners in programs of all-inclusive care for the elderly organizations and beyond," Tabula Rasa Chairman and CEO Calvin Knowlton said in a statement.

In mid-2019, Moorestown, New Jersey-based Tabula Rasa formed a pharmacogenomics delivery and analytics alliance with CQuentia. The previous year, Minneapolis-based OneOme received approval from the New York State Department of Health for RightMed.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.